Cite
HARVARD Citation
Wils, P. et al. (2021). Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Alimentary pharmacology & therapeutics. 53 (4), pp. 460-470. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wils, P. et al. (2021). Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Alimentary pharmacology & therapeutics. 53 (4), pp. 460-470. [Online].